Surgery Partners Inc

Healthcare · Medical Care Facilities

14.20$ -2.5% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

Surgery Partners Inc (SGRY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 849 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement SGRY
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	283	306	286	288	283	460	417	445	444	491	417	445	452	517	441	375	496	548	512	543	559	610	596	615	621	707	666	668	674	735	717	762	770	864	776	826	822	885	811	849	3,366
Cost of Revenue	201	214	212	216	201	339	327	340	334	360	326	340	353	388	366	319	382	413	409	425	437	463	471	481	489	523	532	514	508	542	562	583	593	631	614	631	626	673	689	659	2,647
Gross Profit	81	92	74	72	81	122	90	105	110	131	91	105	99	129	75	55	114	135	104	118	123	147	125	135	131	184	134	154	166	194	155	179	178	234	162	196	195	212	122	190	719
Research & Development	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Selling, General & Administrative	15	18	16	19	36	21	24	26	19	24	22	23	20	24	23	25	25	24	27	25	26	27	30	26	18	29	32	31	37	21	33	40	29	36	36	36	324	127	141	36	628
Total Operating Expenses	38	36	32	36	308	49	46	49	47	42	41	42	38	43	51	11	96	39	39	59	59	32	24	58	57	90	88	57	83	92	79	94	117	107	100	84	90	102	39	88	319
Operating Income	43	68	42	38	43	80	41	44	45	-52	50	56	59	72	24	45	19	96	64	60	64	115	100	77	74	94	46	98	83	101	76	85	61	127	62	112	106	110	82	102	400
Interest Expense	26	26	25	26	26	33	34	36	37	40	42	46	46	45	47	49	52	54	53	53	54	60	56	57	61	61	47	48	50	49	47	52	50	53	62	68	335	193	71	70	668
Pre-Tax Income	13	43	17	12	13	73	6.9	7.6	7.8	-92	5.2	9.1	13	27	-24	-4.5	-33	42	11	6.1	9.4	55	44	20	13	33	-0.4	50	33	53	29	33	11	74	-0.3	44	31	43	-3.3	32	102
Income Tax Expense	-1.7	4.6	2.1	0.5	-1.7	72	1.8	3.3	5.8	16	1.7	1.0	2.4	3.4	-15	-0.6	1.3	-5.6	0.2	-2.7	1.2	12	1.3	4.3	7.8	9.9	-1.6	-7.8	3.1	6.0	4.4	4.9	4.5	121	37	-1.1	5.5	14	-1.2	2.6	21
Net Income	-2.3	17	-2.8	-4.5	14	-32	-18	-19	-21	-148	-20	-20	-16	-18	-28	-33	-62	5.5	-21	-27	-23	-0.1	12	-18	-25	-23	-25	19	-4.9	-1.0	-12	-16	-32	-109	-38	-2.5	-23	-15	-36	-15	-89
EBITDA	49	79	53	49	31	99	57	60	62	-34	66	75	77	92	45	68	43	122	90	85	89	138	128	105	104	124	80	122	112	133	110	120	111	161	98	152	405	295	106	141	948

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings